136 related articles for article (PubMed ID: 22301831)
21. Association between radiologists' and facilities' characteristics and mammography screening detection of ductal carcinoma in situ.
Théberge I; Vandal N; Perron L; Guertin MH
Breast Cancer Res Treat; 2021 May; 187(1):255-266. PubMed ID: 33392846
[TBL] [Abstract][Full Text] [Related]
22. Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis.
Jørgensen KJ; Gøtzsche PC; Kalager M; Zahl PH
Ann Intern Med; 2017 Mar; 166(5):313-323. PubMed ID: 28114661
[TBL] [Abstract][Full Text] [Related]
23. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
[TBL] [Abstract][Full Text] [Related]
24. Modeling the natural history of ductal carcinoma in situ based on population data.
Chootipongchaivat S; van Ravesteyn NT; Li X; Huang H; Weedon-Fekjær H; Ryser MD; Weaver DL; Burnside ES; Heckman-Stoddard BM; de Koning HJ; Lee SJ
Breast Cancer Res; 2020 May; 22(1):53. PubMed ID: 32460821
[TBL] [Abstract][Full Text] [Related]
25. Epidemiologic risk factors for in situ and invasive ductal breast cancer among regularly screened postmenopausal women by grade in the Cancer Prevention Study-II Nutrition Cohort.
Puvanesarajah S; Gapstur SM; Gansler T; Sherman ME; Patel AV; Gaudet MM
Cancer Causes Control; 2020 Jan; 31(1):95-103. PubMed ID: 31802322
[TBL] [Abstract][Full Text] [Related]
26. Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: a report from the Breast Cancer Surveillance Consortium.
Allison KH; Abraham LA; Weaver DL; Tosteson AN; Nelson HD; Onega T; Geller BM; Kerlikowske K; Carney PA; Ichikawa LE; Buist DS; Elmore JG
Cancer; 2015 May; 121(9):1369-78. PubMed ID: 25603785
[TBL] [Abstract][Full Text] [Related]
27. Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer.
Buist DSM; Abraham L; Lee CI; Lee JM; Lehman C; O'Meara ES; Stout NK; Henderson LM; Hill D; Wernli KJ; Haas JS; Tosteson ANA; Kerlikowske K; Onega T;
JAMA Intern Med; 2018 Apr; 178(4):458-468. PubMed ID: 29435556
[TBL] [Abstract][Full Text] [Related]
28. Mode of detection and secular time for ductal carcinoma in situ.
Pisano ED
J Natl Cancer Inst Monogr; 2010; 2010(41):142-4. PubMed ID: 20956819
[TBL] [Abstract][Full Text] [Related]
29. Breast density and risk of breast cancer.
Lynge E; Vejborg I; Lillholm M; Nielsen M; Napolitano G; von Euler-Chelpin M
Int J Cancer; 2023 Mar; 152(6):1150-1158. PubMed ID: 36214783
[TBL] [Abstract][Full Text] [Related]
30. Estimating the natural progression of non-invasive ductal carcinoma in situ breast cancer lesions using screening data.
Weedon-Fekjær H; Li X; Lee S
J Med Screen; 2021 Sep; 28(3):302-310. PubMed ID: 32854582
[TBL] [Abstract][Full Text] [Related]
31. Performance of digital screening mammography among older women in the United States.
Henderson LM; O'Meara ES; Braithwaite D; Onega T;
Cancer; 2015 May; 121(9):1379-86. PubMed ID: 25537958
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer incidence and menopausal hormone therapy in Norway from 2004 to 2009: a register-based cohort study.
Suhrke P; Zahl PH
Cancer Med; 2015 Aug; 4(8):1303-8. PubMed ID: 25991514
[TBL] [Abstract][Full Text] [Related]
33. Detection Rate, Recall Rate, and Positive Predictive Value of Digital Compared to Screen-Film Mammography in the Quebec Population-Based Breast Cancer Screening Program.
Théberge I; Vandal N; Langlois A; Pelletier É; Brisson J
Can Assoc Radiol J; 2016 Nov; 67(4):330-338. PubMed ID: 27451910
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a mammography screening program within the population-based Vorarlberg Health Monitoring & Prevention Program (VHM&PP).
Nagel G; Oberaigner W; Peter RS; Ulmer H; Concin H
Cancer Epidemiol; 2015 Dec; 39(6):812-8. PubMed ID: 26651439
[TBL] [Abstract][Full Text] [Related]
35. Effect of implementing digital breast tomosynthesis (DBT) instead of mammography on population screening outcomes including interval cancer rates: Results of the Trento DBT pilot evaluation.
Bernardi D; Gentilini MA; De Nisi M; Pellegrini M; Fantò C; Valentini M; Sabatino V; Luparia A; Houssami N
Breast; 2020 Apr; 50():135-140. PubMed ID: 31607526
[TBL] [Abstract][Full Text] [Related]
36. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial.
Hofvind S; Holen ÅS; Aase HS; Houssami N; Sebuødegård S; Moger TA; Haldorsen IS; Akslen LA
Lancet Oncol; 2019 Jun; 20(6):795-805. PubMed ID: 31078459
[TBL] [Abstract][Full Text] [Related]
37. Recent breast cancer incidence trends according to hormone therapy use: the California Teachers Study cohort.
Marshall SF; Clarke CA; Deapen D; Henderson K; Largent J; Neuhausen SL; Reynolds P; Ursin G; Horn-Ross PL; Stram DO; Templeman C; Bernstein L
Breast Cancer Res; 2010; 12(1):R4. PubMed ID: 20064209
[TBL] [Abstract][Full Text] [Related]
38. Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
Kuhl CK; Strobel K; Bieling H; Leutner C; Schild HH; Schrading S
Radiology; 2017 May; 283(2):361-370. PubMed ID: 28221097
[TBL] [Abstract][Full Text] [Related]
39. Non-progressive breast carcinomas detected at mammography screening: a population study.
Heggland T; Vatten LJ; Opdahl S; Weedon-Fekjær H
Breast Cancer Res; 2023 Jul; 25(1):80. PubMed ID: 37403150
[TBL] [Abstract][Full Text] [Related]
40. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
